Revolve Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.68M Sell
12,937
-361
-3% -$124K 0.49% 39
2026
Q1
$4.68M Sell
13,298
-613
-4% -$219K 0.61% 31
2025
Q4
$4.55M Sell
13,911
-550
-4% -$174K 0.54% 34
2025
Q3
$4.08M Sell
14,461
-666
-4% -$193K 0.49% 36
2025
Q2
$4.22M Sell
15,127
-370
-2% -$105K 0.55% 34
2025
Q1
$4.83M Sell
15,497
-826
-5% -$244K 0.7% 29
2024
Q4
$4.25M Sell
16,323
-350
-2% -$104K 0.62% 31
2024
Q3
$5.37M Sell
16,673
-275
-2% -$90K 0.82% 24
2024
Q2
$5.3M Sell
16,948
-411
-2% -$121K 0.87% 24
2024
Q1
$4.94M Sell
17,359
-94
-0.5% -$27.5K 0.84% 24
2023
Q4
$5.03M Buy
17,453
+2
+0% +$545 0.97% 24
2023
Q3
$4.69M Buy
17,451
+165
+1% +$41.2K 1.08% 22
2023
Q2
$3.84M Buy
17,286
+45
+0.3% +$10.4K 0.9% 25
2023
Q1
$4.17M Sell
17,241
-121
-0.7% -$29.7K 1.06% 22
2022
Q4
$4.56M Sell
17,362
-1,616
-9% -$433K 1.3% 19
2022
Q3
$4.28M Buy
18,978
+69
+0.4% +$16.7K 1.43% 19
2022
Q2
$4.6M Buy
18,909
+74
+0.4% +$18.1K 1.51% 17
2022
Q1
$4.55M Sell
18,835
-9,689
-34% -$2.23M 1.31% 20
2021
Q4
$6.42M Buy
+28,524
New +$6.02M 1.85% 13

Other funds holding AMGN

Revolve Wealth Partners's AMGN Position: Q2 2026 in Review

Revolve Wealth Partners reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $124K and leaving 12,937 shares worth $4.68M. The position accounts for 0.49% of the portfolio, ranked #39.

Revolve Wealth Partners first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.42M in Q4 2021. 1,282 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Revolve Wealth Partners held 12,937 shares of Amgen worth $4.68M as of Q2 2026.
  • Revolve Wealth Partners sold 361 Amgen shares in Q2 2026, an estimated $124K.
  • Amgen made up 0.49% of Revolve Wealth Partners's portfolio in Q2 2026, its #39 holding.
  • Revolve Wealth Partners first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • Revolve Wealth Partners's Amgen position peaked at $6.42M in Q4 2021.
  • 1,282 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Revolve Wealth Partners's 13F filing for Q2 2026, filed 9 Jul 2026.